Introduction
Malignant melanoma is the most aggressive skin cancer and remains one of the most deadly malignant tumours in Western population. Metastatic melanoma cells tend to disseminate to multiple organs including brain, lung, liver or bone, rendering surgical interventions of limited use and success (1) . Currently, no effective therapy is available for metastatic melanoma (2) . Although chemotherapeutic drugs could theoretically target all metastatic sites, recent treatments do not provide efficient therapeutics (3) . Metastatic cancers including melanoma are frequently associated with increased resistance to apoptosis induced by various therapeutic modalities (4, 5) , and the success of systemic therapy for the treatment of metastatic melanoma is minimal (6, 7) . Thus, the ineffectiveness of a wide range of antineoplastic treatments to kill melanoma cells implies that the resistance mechanisms in melanoma are complex and melanoma is notoriously refractory to standard drugs (8) .
Cancer chemotherapeutic efficacy is frequently impaired by either intrinsic or acquired tumour resistance to multiple structurally unrelated therapeutic drugs with different mechanisms of action (9) . However, the reasons for chemoresistance are diverse and may be caused by either reduced effective concentration of the drug or diminished presence of the drug's target(s) (9, 10) . Endoplasmic reticulum (ER) plays an important role in maintenance of intracellular calcium homeostasis, protein synthesis, posttranslational modifications and proper folding of proteins as well as their sorting and trafficking. Alterations in calcium homeostasis and accumulation of unfolded proteins cause ER stress. A variety of different agents including chemical toxicants, oxidative stress, and inhibitors of protein glycosylation, calcium homeostasis (11) or disturbed ER membrane integrity caused by pro-apoptotic proteins including Noxa (12) can induce ER stress leading to cell death. Nevertheless, the relative role of pro-apoptotic ER stress signalling in the modulation of apoptosis is not clear. Multiple pathways may be involved in ER stress-initiated apoptosis; in most cases these converge on the mitochondria (13) . Importantly, a recent report described Noxa that the sustained calcium accumulation in the mitochondrial matrix is induced by ER stress and is considered a new trigger of apoptosis by causing permeability transition, dissipation of the electrochemical potential, relocalization of BH3-only proteins to mitochondria and thereby triggers mitochondrial apoptotic pathway that is characterized by the release of Cytochrome c into the cytoplasm and subsequently the cleavage of downstream caspases (2, 14) .
Here, we confirmed, in vitro, the reliability of the apoptosis-related protein (APR) -2 to overcome melanoma resistance to current therapies by a mechanism including both mitochondrial and nonmitochondrial-dependent pathways.
Material and methods

Cell lines
The melanoma cell lines A375 and BLM were obtained from American Type Culture Collection (ATCC, Manasses, VA), and cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and 100 U/ml penicillin and 100 lg/ml streptomycin. Both normal human fibroblasts (NHF) and normal human melanocytes (NHM) are gifts form Dr A.Mirmohammadsadegh, Institute of Pathology, University of Bochum.
Reagents and inhibitors
Inositol-requiring enzyme (IRE) 1a inhibitor (Irestatin 938) was purchased from Hoffmann & Co Ltd of Basel, Switzerland, calpain inhibitor (ALLM) from Enzo Life Science, Loerrach, Germany, Inhibitor of ASK1 (Thioredoxin) from MERK (Darmstadt, Germany), inhibitor of c-Jun-N-terminal kinase (JNK) (SP600125) from Biomol, Loerrach, Germany; caspase-4 inhibitor (Z-YVAD-FMK) from R&D Systems, Bad Nauheim, Germany.
Establishment of melanoma cell lines for regulated expression of APR-2 Melanoma (A375-TetOn and BLM-TetOn) cells were generated using the TetOn expression system (Clontech Inc. Mountain View, CA) as described previously (15) (16) (17) . Briefly, the melanoma cell lines (A375 and BLM) were transfected with pTet-On plasmid. Twenty-four hours later, the transfected cells were challenged with G418 (600 lg/ml) for selection. After 6 weeks, single clones were selected and expanded. The selected clones (A375-TetOn Abbreviations: APR, apoptosis-related protein; ASK, apoptosis signal-regulating kinase; ATM, ataxia telangiectsia mutated; ER, endoplasmic reticulum; EMSA, electrophoretic mobility shift assay; IRE, inositol-requiring enzyme; JNK, c-Jun-N-terminal kinase; MTT, 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide; NHF, normal human fibroblast; NHM, normal human melanocyte; PARP, poly adenosine diphosphate ribose polymerase; PI, propidium iodide. and BLM-TetOn) were transfected with pTRE2hyg-luciferase vector and tested for their induction efficiency by the addition of Dox (10 ng/ml) for 24 h. The induction level of each clone was determined using the luciferase assay as described previously (18, 19) . Clones with high-induction level and low background were chosen for transfection with pTRE2hyg-APR-2. Cells were cultured in the presence of both, G418 (600 lg/ml) and hygromycin (300 lg/ ml). Selected clones were isolated, expanded and further examined for APR-2 expression by quantitative reverse transcription-polymerase chain reaction. Clones with high-induction levels were chosen for the functional analysis of APR-2 protein.
Transfection of NHF and NHM cells with APR-2
The transfection of both NHF and NHM with APR-2 plasmid using Xfect TM transfection reagent was performed as recommended by the manufacturer (Clontech Laboratories). Briefly, 24 h prior to the transfection, both NHF and NHM cells were plated so that the cells become 50-80% confluent at the time of transfection. Just prior to the preparation of transfection complexes, the cells were plated at a concentration of 5 Â 10 5 -1.25 Â 10 6 in 1 ml of growth medium. After the incubation of the samples for 10 min at room temperature, the transfection solution (600 ll) was added dropwise to the culture medium with gently rocking of the plate. Finally, the plates were incubated at 37°C under normal condition. Fourty-eight hours later, the cells were harvested and subsequently subjected to either flow cytometry analysis or for the preparation of total cell lysates and nuclear extracts.
Assessment of cell survival
The melanoma (A375-APR-2 and BLM-APR-2) cells in exponential growth phase were allowed to grow in the presence of G418 (600 lg/ml) and puromycin (10 lg/ml) before the induction of APR-2 protein by the addition of Dox (10 ng/ml) for different time intervals up to 72 h. The cell viability was determined using the 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay as described previously (20) .
Flow cytometric analysis
The detection of apoptosis using annexin V/propidium iodide (PI) staining was performed as described (12, 21) , the measurement of mitochondrial membrane potential (DW m ) was performed using JC-1 staining as described (15, 21) , and the measurement of intracellular calcium Ca 2þ release into the cytosol of A375-APR-2 and BLM-APR-2 cells were monitored using Ca 2þ -sensitive dye Fluo3-AM (Invitrogen, Karlsruhe, Germany) as described (22) .
Immunoblot
Immunoblot analysis was performed according to the standard procedures. The following antibodies and dilutions were used: Anti-APR-2 (Biogenes, Berlin, Germany) 1:500; anti-ASK1 (Sc-7931), 1:1.000; anti-JNK (Sc-474), 1:1.000; anti-p38 (Sc-535), 1:1.000; anti-ERK (Sc-154-G), 1:1.000; anti-caspase-4 (Sc-1227), 1:1000; anti-Tom20 (Sc-11415), 1:100; anti-Bap31 (Sc-17764), 1:500; anti-calpain (Sc-7530), 1:1000; anti-Actin (Sc-1615), 1:2.000; anti-IRE1a (Sc-20790), 1:500; anti-calpain 1 (Sc-7530), 1:1000 (Santa Cruz Biotechnology, Santa Cruz, CA), 1:1000, anti-phospho-IRE1a (PA1-16927; Thermo Scientific), 1:1000; anti-caspase-3 (#7190), 1:1.000; anti-caspase-9 (#9501), 1:1.000; anti-poly adenosine diphosphate ribose polymerase (PARP, #9542), 1:1000; anti-Bax (#2772) 1:1000; Bak (#3814), 1:1000; (each Cell Signaling Technology, Danvers, MA) and anti-Cytochrome c (ab1357-100; Abcam, Cambridge, MA), 1:1.000, Anti-ataxia telangiectsia mutated (ATM) (Sc-23922; Santa Cruz Biotechnology), 1:500; Anti-phospho-ATM (#4526; Cell Signaling Technology), 1:500.
Immunofluorescence staining A375-APR-2 and BLM-APR-2 cells were allowed to grow for 24 h before the induction of APR-2 expression was performed by the addition of Dox (10 ng/m) for the indicated time periods. Then the cells were subjected to immunofluorescence staining as described (15) . Primarily, anti-APR-2 (Biogenes, Berlin, Germany), anti-Tom20, anti-Bap31 antibodies (each Santa Cruz Biotechnology) or anti-Bax (Cell Signaling Technology) were allowed to bind overnight at 4°C. Subsequently, the cells were washed three times in phosphate-buffered saline and incubated with Alexa Flour-labelled secondary antibodies. After additional three washes in phosphate-buffered saline, the cells were mounted using DAKO mounting medium. Pictures were taken on a confocal laser Scanning Microscopy (Leica, Wetzlar, Germany).
Cell lysis and subcellular fractionation Total and nuclear cell extracts were prepared from both melanoma A375-APR-2 and BLM-APR-2 clones as described previously (16) . In addition, the preparation of both mitochondrial and ER fractions were performed as described (12) .
In vitro kinase assays In vitro kinase assays were performed as described previously (15) . Briefly, cell lysates were incubated with specific antibodies to ASK1 or JNK (each Santa Cruz Biotechnology) for 1 h at 4°C. Following the binding to protein-A (5 mg/ml) and three washings, kinase activity was determined by the incubation with 2 lg of GST-c-jun (1-79aa) protein (Biomol, Hamburg, Germany) as substrate for JNK or 2 lg of MBP protein (Upstate Biotechnology, Eching, Germany) as substrate for ASK1, ERK and p38, and 10 lCi of [c- 
Electrophoretic mobility shift assay
The details of electrophoretic mobility shift assay (EMSA) have been described previously (21) . Briefly, the double-stranded synthetic oligonucleotides carrying a consensus sequence for AP-1 or p53 (Santa Cruz Biotechnology) were end labelled with [c- 32 P] ATP (Hartmann Analytika, Munich, Germany) in the presence of T4 polynucleotide kinase (Genecraft, Muenster, Germany). The competition assay was performed in the same manner, except that unlabelled probes containing AP-1 and p53 sequences were incubated with nuclear extracts for 20 min before adding the labelled probes. After electrophoresis, the gels were drayed and bands were visualized by exposure to high performance autoradiography film.
Application of siRNAs
The knock-down of Bim by its specific siRNA (# 6461; Cell Signaling Technology), the knockdown of protein kinase RNA-like endoplasmic reticulum kinase (PERK) by its specific siRNA (SC-36213; Santa Cruz Biotechnology) as well as the knock-down of ATM by its specific siRNA (# SR300330; OriGene Technologies, Rockville, MD) were performed as recommended by manufacturer's protocol.
Results
Generation of melanoma cell lines for regulated expression of APR-2
To examine the ability of APR-2 protein to trigger apoptosis of melanoma cells and to elucidate the underlying mechanisms, we established A375 and BLM cell lines for tetracycline (Tc)/doxycycline (Dox)-inducible expression of APR-2 protein (15). We initially generated A375-TetOn and BLM/TetOn cell lines that constitutively express the tetracycline regulated transactivator, rtTA. These cell lines were transfected with a vector for tetracycline-regulated expression of luciferase (pTRE/luciferase) and the induction of luciferase activity was assessed luminometrically. Clones with high-induction level of luciferase activity were selected and termed as A375-TetOn and BLM-TetOn (data not shown). Both A375-TetOn and BLM-TetOn cell lines were then transfected with pTRE-APR-2 plasmids and subjected to further selection to generate A375-APR-2 and BLM-APR-2 clones. Tightly regulated expression of APR-2 protein by Dox was found to be dose ( Figure 1A ) and time ( Figure 1B ) dependent. Next, we investigated the killing efficiency of APR-2 in both A375-APR-2 and BLM-APR-2 cells using annexin V/PI staining. Data obtained from flow cytometric analysis ( Figure 1C ) demonstrated the ability of APR-2 to kill melanoma cells by an apoptotic mechanism. Thus, we further investigated the molecular mechanisms of APR-2-induced apoptosis; we firstly examined the subcellular localization of APR-2 in BLM-APR-2 cells. Following the induction of APR-2 protein for 12 h, the cells were fixed and subsequently subjected for the staining with antibodies against Tom20 and Bap31 as specific markers for mitochondria and ER, respectively, and co-stained with anti-APR-2 antibody. Confocal laser scanning microscopy demonstrated the localization of APR-2 protein at ER, but not at mitochondria ( Figure 1D ). To further confirm immune fluorescence data, we prepared the subcellular fractions of mitochondria and ER for western blot analysis. Data obtained from western blot analysis ( Figure 1E ) confirmed the subcellular localization of APR-2 protein at ER as evidenced by the detection of APR-2 in ER fractions. To investigate whether APR-2-induced apoptosis is associated with ER stress, we set out to measure the level of intracellular Ca 2þ in the cytoplasm of APR-2-expressing cells. We therefore induced APR-2 expression in A375-APR-2 and BLM-APR-2 cells for different time intervals up to 48 h and then incubated the cells with the Ca 2þ -sensitive dye Fluo3-AM (Figure 2A) . The induction of APR-2 expression in both melanoma cell lines resulted in APR-2 triggers apoptosis of melanoma cells a time-dependent increase of intercellular Ca 2þ , providing evidence for APR-2-induced ER stress in melanoma cells, and thereby suggests the contribution of ER pathway(s) in the modulation of APR-2-induced apoptosis.
To investigate whether APR-2-induced Ca 2þ release is associated with the modulation of ER pathways including IRE1a/ASK1/JNK, PERK/ATF4/CHOP and/or calpain/caspase-4, we analysed IRE1a, ASK1, JNK, PERK, ATF4, CHOP, calpain, caspase-4 and Bim in melanoma cells following the induction of APR-2 expression. Although no changes were noted at the expression level of IRE1a, the accumulation of APR-2 protein was found to enhance its phosphorylation when compared with control cells (Figure 2B ). Moreover, we examined whether APR-2-induced ER stress is associated with the degradation of calpain and/or cleavage of caspase-4, as markers for ER stress. Western blot analysis ( Figure 2C ) demonstrated the degradation of calpain together with the cleavage of caspase-4 in response to the induction of APR-2 protein. Also, the role of PERK pathway in the modulation of APR-2-induced ER stress was analysed. Using western blot analysis ( Figure 2D ), we could show the phosphorylation of PERK and the induction of CHOP, ATF4 and Bim proteins in APR-2-expressing cells. In addition, the analysis of the nuclear extracts of APR-2-expressing cells using EMSA ( Figure 2E ) demonstrated the enhancement of the DNA-binding activity of CHOP. Taken together, these data suggest an important role for ER stress-associated pathways in the modulation of APR-2-induced apoptosis of melanoma cells. and mitochondria using confocal laser scanning microscopy. BLM-APR-2 allowed to grow for 24 h in the absence or in the presence of Dox (10 ng/ml) before the staining with anti-APR-2 antibody (green); mitochondria and ER were detected by staining for the marker proteins Tom20 (blue) and Bap31 (red), respectively. The overlay with Tom20 and Bap31 staining demonstrates the localization of APR-2 at ER (yellow), but not to mitochondria (green/blue). (E) Western blot analysis of APR-2 expression in different subcellular fractions. APR-2 expression was analysed in mitochondrial (Mito) and ER fractions of A375-APR-2 and BLM-APR-2 clones allowed to grow in the absence or in the presence of Dox (10 ng/ml) for 24 h. The purity of the fractions was verified by immunoblotting for the mitochondrial protein Tom20 and the ER marker Bap31 protein. Data are representative of three independent experiments with similar results.
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Expression of APR-2 protein in melanoma cells triggers mitochondrial damage and activation of ASK1/JNK pathway Next, we set out to address the role of the mitochondria in the modulation of APR-2-indued apoptosis, and we started with the measurement of the mitochondrial membrane potential (Dw m ) by flow cytometric analysis using JC-1 staining before and after the induction of APR-2 protein in melanoma cells. Flow cytometric analysis ( Figure 3A ) demonstrated the loss of Dw m by the induction of APR-2 protein, suggesting a possible role for mitochondrial pathway(s) in the modulation of APR-2-induced melanoma cell death. To verify APR-2-induced mitochondrial dysregulation, we analysed the molecular markers of apoptosis including Cytochrome c, caspase-9, caspase-3 and PARP using western blot analysis. The induction of APR-2 protein was found to enhance the release of Cytochrome c from mitochondria into the cytoplasm together with the cleavage of caspase-9, caspase-3 and PARP ( Figure 3B ), suggesting the involvement of mitochondrial apoptotic pathways in the modulation of APR-2-induced apoptosis.
We investigated the role of mitogen-activated protein kinase-signalling pathways in the context of APR-2-induced apoptosis. The melanoma cells were induced for the expression of APR-2 by the addition of Dox (10 ng/ml) to the culture medium. Twenty-four hours later, total cell lysates and nuclear extracts were prepared and subjected for western blot analysis, in vitro kinase assay and EMSAs. Although no alteration was noted at the expression level of either apoptosis signal-regulating kinase 1 (ASK1), JNK, p38 or extracellular regulated kinase (ERK), when compared with control cells, the induction of APR-2 protein was found to enhance the activation of ASK1 and JNK without influencing the basal activities of p38 or ERK pathways ( Figure 3C) . Also, the analysis of the DNA-binding activities of the transcription factors AP-1 and p53 by EMSA ( Figure 3D and E) demonstrated the activation of the transcription factors AP-1 and p53. In addition, we could show the induction of Bax, but not Bak expression in APR-2-expressing cells ( Figure 3F ). Furthermore, the subcellular localization of Bax protein in APR-2-expressing cells using immune fluorescence staining of Bax, Tom20 (as marker for mitochondria) and Bap31 (as marker for ER) ( Figure 3G ) demonstrated the localization of Bax to both ER and mitochondria, suggesting an important role for Bax in the modulation of APR-2-induced apoptosis. Next, we confirmed the subcellular localization of Bax to both mitochondria and ER by the analysis of subcellular fractions of both, mitochondria and ER using western blot ( Figure 3H ). 
APR-2-induced apoptosis of melanoma cells is mediated by ER stress via mitochondrial and non-mitochondrial-dependent mechanisms
To determine, in detail, the molecular mechanisms, whereby APR-2 triggers apoptosis of melanoma cells, we set out to perform experiments using the specific inhibitors for IRE1a (irestatin), calpain (ALLM), JNK (SP600125), caspase-4 (Z-LEVD-FMK), and ASK1 (Thioredoxin). The pretreatment of both A375-APR-2 and BLM-APR-2 cells with irestatin before the induction of APR-2 protein suppressed APR-2-induced activation of both, ASK1 and JNK ( Figure 4A) , and subsequently the activation of the transcription factors AP-1 ( Figure 4B ) and p53 ( Figure 4C) . Also, the inhibition of both APR-2-induced Bax protein and Cytochrome c release by the inhibitor of IRE1a ( Figure 4D ) suggests the involvement of IRE1a in the regulation of the ASK1/JNK-AP-1/p53 pathway, which presumably is responsible for APR-2-mediated induction of Bax leading to both ER stress and mitochondrial dysregulation. Next, we analysed the effect of calpain inhibitor (ALLM) on APR-2-induced cleavage of caspase-4. Both A375-APR-2 and BLM-APR-2 cells were pretreated with ALLM prior to the induction of APR-2 expression for 24 h, and the total cell lysates were prepared for western blot analysis using specific antibodies for caspase-4. As expected, the inhibition of calpain was found to block APR-2-induced cleavage of caspase-4 ( Figure 4E ), indicating the involvement of calpain in APR-2-induced cleavage of caspase-4. Furthermore, we also investigated the effect of the above mentioned inhibitors of calpain (ALLM), PERK (siRNA), IRE1a (irestatin), JNK (SP600125) and ASK1 (thioredoxin) on the extent of APR-2-induced cell death using the MTT assay 
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( Figure 5A and B) . These analyses demonstrated partial inhibition of APR-2-induced death of melanoma cells in the presence of the inhibitors of calpain, PERK, IRE1a, ASK1 or JNK. In contrast, the combination of ALLM with irestatin, thioredoxin or SP600125 almost completely blocked APR-2-induced cell death, whereas the combination of irestatin with either thioredoxin or SP600125 was only slightly less efficient ( Figure 5A ). Although the knockdown of PERK by its specific siRNA together with the combination of either the inhibitor of calpain or the inhibitor of IRE1a blocked, in part, APR-2-induced apoptosis, the inhibition of PERK, calpain and IRE1a simultaneously was found to abrogate APR-2-induced cell death in both A375 and BLM cells ( Figure 5B ). Taken together, these data suggest that APR-2-induced death of melanoma cells is mediated by three parallel pathways namely IRE1a-ASK1/JNK, PERK/ATF4/CHOP/Bim and calpain-caspase-4 and revealed that only their simultaneous inhibition efficiently blocks APR-2-induced apoptosis. 
Verification of APR-2-induced apoptosis in normal human cells
To examine whether the over-expression of APR-2 triggers also apoptosis of NHF and/or those of NHM. The cells were transfected with either APR-2 plasmid or empty vector. Forty-eight hours later, the cells were subjected either to flow cytometry analysis using annexin V/PI staining for the detection of apoptosis or to western blot analysis for the detection of PARP cleavage. Flow cytometry analysis using annexin V/PI staining ( Figure 6A ) demonstrated that the constitutive expression of APR-2 leads to the induction of apoptosis of both NHF and NHM cells. Also, data obtained from western blot analysis using antibody specific to PARP ( Figure 6B ) demonstrated the cleavage of PARP in APR-2-expressing cells and confirmed the ability of APR-2 to kill both NHF and NHM cells by an apoptotic mechanism.
The role of ATM in the regulation of APR-2-induced activation of p53 To address the role of ATM in the regulation of APR-2-induced p53 activation and subsequently apoptosis, we examined first both the expression and the phosphorylation levels in APR-2-expressing cells including A375-APR-2, BLM-APR-2, NHF-APR-2 and NHM-APR-2 cells as well as in control cells using western blot analysis. The over-expression of APR-2 either in melanoma cells (A375-APR-2, BLM-APR-2) or normal human cells (NHF, NHM) does not appear to influence ATM either at expression or at phosphorylation levels ( Figure 7A ). Although no marked effect was noted on the status of ATM in tested cells, we set out to suppress ATM protein by its specific siRNA and to examine the effect of ATM suppression on the extension APR-2-induced activation of p53 in A375-APR-2, BLM-APR-2, NHF and NHM cells. The melanoma cell lines A375-APR-2, BLM-APR-2, NHF and NHM cells were transfected with ATM-specific siRNA 24 h prior to the induction of APR-2 in both A375-APR-2 and BLM-APR-2 cells by the addition of Dox (10 ng/ml) for 24 h or the transfection of NHF and NHM cells with pcDNA-APR-2 plasmids for 24 h. Next, the cells were harvested for the preparation of total cell lysate and nuclear extracts or subjected for the measurement of cell viability using MTT assay. Firstly, we analysed the expression level of ATM protein in siRNA transfected and control cells by immune blotting. As expected the transfection with ATM-specific siRNA efficiently reduced the basal levels of ATM in melanoma cells including A375-APR-2 and BLM-APR-2 cells ( Figure 7B ) or normal human cells including NHM and NHF cells ( Figure 7C ) as evidenced by western blot. Next, we examined the effect of the suppression of ATM protein on APR-2-induced DNA-binding activities of the transcription factor p53 in A375-APR-2, BLM-APR-2, NHF and NHM cells. The analysis of the nuclear extracts of APR-2-expressing and control cells using EMSA demonstrated that the suppression of ATM protein by its specific siRNA does not influence APR-2-induced p53 activation in A375-APR-2 ( Figure 7D ), BLM-APR-2 ( Figure 7E ), NHF ( Figure  7F ) and NHM ( Figure 7G ), suggesting that APR-2-induced p53 activation is not mediated by ATM protein kinase. In addition, we examined the effect of ATM suppression on the extension of APR-2-induced cell death of both melanoma (A375-APR-2 and BLM-APR-2) and normal human (NHF and NHM) cells. Data obtained from cell viability assay ( Figure 7H ) demonstrated that the abrogation of ATM by its specific siRNA does not appear to influence APR-2-induced death of either melanoma (A375-APR-2 and BLM-APR-2) or normal human (NHF and NHM) cells. Taken together, the obtained data suggest that the ATM protein kinase are not involved either in the regulation of APR-2-induced p53 activation or in the modulation of apoptosis.
Discussion
The present study demonstrates the reliability of APR-2 to trigger ER stress that, in turn, mediates apoptosis of melanoma cells via a mechanism including both mitochondrial and non-mitochondria-dependent pathways.
APR-2 protein belongs to a protein family that was found to be crucial for Fas-induced apoptosis in different tumour cell types including melanoma (20) as well as during all-trans-retinoic acid-induced apoptosis of human promyelocytic leukaemia cells (23) . Further analysis of APR-2 in melanoma cells confirmed its pro-apoptotic function that is mediated by its subcellular localization at ER leading to ER stress that seems to be the initial step in the modulation of APR-2-induced apoptosis.
Currently, the potential of ER stress in tumour therapy is unproved. Although the response of ER stress is presumably important for regulating the balance between tumour cell death and growth as well as for the sensitivity to chemotherapeutic agents, its upcoming as a new focal site for the initiation of intrinsically mediated cell death is not studied in detail (6, 12, (23) (24) (25) . ER plays an important role in the maintenance of intracellular calcium homeostasis, protein synthesis, posttranslational modifications and proper folding of proteins as well as their sorting and trafficking. Hence, the alterations in calcium homeostasis and accumulation of unfolded proteins result in the induction of ER stress, which is sensed by ER-resident transmembrane proteins, i.e. pancreatic ER kinase (PERK), IRE1 and activating transcription factor 6 (ATF6) (26) . The release of Ca 2þ from the ER into the cytoplasm has been implicated as a key-signalling event in many models of apoptosis and it may sensitize mitochondria to trigger apoptotic cell death. In addition, an increasing number of ER proteins APR-2 triggers apoptosis of melanoma cells have been described to influence apoptosis by either interacting with Bcl-2 family members or altering ER Ca 2þ responses. Also, several ER proteins are caspase substrates that may regulate the execution phase of apoptosis (27) .
Our results revealed that the induction of APR-2 protein in melanoma cells results in the induction of ER stress leading to the release of intracellular Ca 2þ that triggers: (i) a caspase-4-dependent pathway, via, calpain activation, (ii) a mitochondrial-dependent apoptotic pathway via IRE1a/ASK1/JNK cascade and (iii) a mitochondrialindependent apoptotic pathway via PERK/ATF4/CHOP/Bim cascade.
The pro-apoptotic proteins including Bax and Bak play a key role in the alteration of mitochondrial membrane potential (Dw m ) that, in turn, leads to the release of mitochondrial apoptogenic factors. Therefore, we investigated the role of the IRE1a/ASK1/JNK cascade in the regulation of Bax to define the mechanism, whereby APR-2 induces mitochondrial dysregulation. Accordingly, our data demonstrated the ability of APR-2 to enhance Bax expression and subsequently, its translocation to mitochondria leading to the loss of Dw m and subsequently, the release of Cytochrome c and the cleavage of caspase-9, caspase-3 and PARP. Generally, in response to ER stress, Bax and Bak undergo conformational changes to cause the release of Ca 2þ from ER lumen into cytoplasm, followed by the activation of calpain (24) . Upon exposure to Ca 2þ , calpain subunits undergo autocleavage, which facilitates activation and ultimately leads to calpain degradation (28) . Beside the participation in apoptosis by cleaving either pro-apoptotic and anti-apoptotic proteins based on the nature of stimuli and type of cells involved (29) , calpain has been reported to cleave caspase-4 that is supposed to function in ER stress-mediated apoptosis (30) . However, the role of ER in the modulation of different cell functions including apoptosis is widely reported (12) . Upon ER stress, IRE1 becomes phosphorylated to recruit tumour necrosis factor receptor-associated factor 2 to form a complex, which subsequently activates ASK1 (31) . The active ASK1, in turn, activates JNK, which results in the enhancement of the binding activity of its physiological substrates AP-1 (12) and p53 (32) , which seem to be essential for the regulation of APR-2-induced Bax expression.
In addition to the increase of intracellular Ca 2þ , our data demonstrated the ability of APR-2 to enhance calpain activation leading to the cleavage of caspase-4. Thus, APR-2-induced caspase-4 activation seems to mediate at least, in part, the cleavage of caspase-9. However, based on its similarity to caspase-12, caspase-4 has been reported to be involved in the cleavage of caspase-9 independently from Cytochrome c release (33, 34) .
In the present study, we addressed an important role for p53 in the context of APR-2-induced apoptosis of melanoma cells. Although the involvement of different mechanisms including JNK (32) and ATM kinase (35, 36) in the regulation of p53 during DNA damage, we set out to determine mechanism of APR-2-induced activation of p53. Thus, besides the role of JNK in APR-2-induced activation of p53, we analysed also the role of ATM kinase as an important player in the context of p53 regulation during DNA damage in melanoma and normal human cells. ATM kinase has been reported to be involved both directly (35) and indirectly (36) in the activation of p53 in cell types. However, although the important role of ATM in the regulation of p53 machinery in response to DNA damage, our data revealed the involvement of JNK, but not ATM in the regulation of p53 during APR-2-induced apoptosis of both melanoma and normal human cells.
In conclusion, in addition to the killing efficiency of APR-2 gene transfer, our current data provide evidence for the involvement of three parallel pathways in APR-2-induced apoptosis: one of them (IRE1/tumor necrosis factor receptor-associated factor 2/ASK1/ JNK/Cyt.c/caspase-9/caspase-3/PARP) seems to be mitochondrial dependent, whereas, the other two pathways namely calpain/caspase-4/ caspase-9/caspase-3/PARP and PERK/ATF4/CHOP/Bim seem to be mitochondrial independent (Figure 8) . Thus, utilization of APR-2 gene transfer as a complementary approach for the treatment of chemoresistance melanoma metastasis is considered.
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German Research Foundation (HA 5081/3-1 to M.H.). release and activation of PERK and IRE1a. Whereas, the increase of intracellular Ca 2þ release results in the activation of calpain that subsequently enhances the cleavage of caspase-4 with subsequent cleavage of caspase-9, caspase-3 and PARP. On the other hand, the activation of IRE1a mediates the activation of ASK1 and its downstream kinase, JNK that is implicated in the enhancement of the DNA-binding activities of the transcription factors AP-1 and p53 that, in turn, induce Bax expression. In addition, the activation of PERK leads to the induction of ATF4, and subsequently, the induction and activation of the transcription factor CHOP, together with the induction of Bim expression that may contribute to APR-2-induced apoptosis. The localization of Bax to ER increases APR-2-induced stress, whereas, the localization of Bax to mitochondria causes the loss of mitochondrial membrane potential (Dw m ) with the subsequent release of Cytochrome c and cleavage of caspase-9, caspase-3 and PARP and other substrates, thereby mediating APR-2-induced apoptosis of melanoma cells.
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